GlaxoSmithKline - Biotech, Pharma and Life Science Channel
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009.
Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the products. As well as medications, GSK has an extensive vaccine program, delivering 1.4bn doses in 2020. In 2009, they launched ViiV Healthcare, a global specialist HIV company established by GlaxoSmithKline and Pfizer to deliver advances in treatment and care for people living with HIV.
GSK also produce products such as Ribena, Horlicks, Lucozade, Aquafresh and Sensodyne, as well as traditional medications such as Panadol amongst others.
Source; BioPortfolio.com and GSK.com
Add the GSK News Channel to your RSS reader;
Follow the GSK Twitter feed;
News Articles
GlaxoSmithKline (GSK) today announced a new commitment to the GAVI Alliance to supply its cervical cancer vaccine as part of a new long term programme to help protect girls against cervical cancer in...
GlaxoSmithKline (GSK) today announced progress on its commitment to share more detailed data from its clinical trials.
Funding boost for GSK’s open innovation research into diseases affecting the developing world
GlaxoSmithKline plc (GSK) today announced a funding injection of up to £5m from the Wellcome Trust to support its open approach to discovering and developing urgently needed new treatments for di...
GSK announces regulatory submission for umeclidinium monotherapy in US
GlaxoSmithKline plc today announced the submission of a regulatory application in the US for the investigational once-daily medicine, umeclidinium bromide (UMEC), for patients with chronic obstructive...
LONDON, April 30, 2013 /PRNewswire/ -- This year, 100 strategic decision-makers will meet at the Enterprise Mobility Exchange (21-23 May 2013, Rotterdam) to discuss the challenges presented in achiev...
GlaxoSmithKline and Impax Pharmaceuticals terminate their collaboration on IPX066
GlaxoSmithKline (GSK) plc and Impax Pharmaceuticals today announced that they are terminating their collaboration for the development and commercialisation of IPX066 outside the United States and Taiw...
GSK announces regulatory submission for umeclidinium monotherapy in European Union
GlaxoSmithKline plc (LSE:GSK) today announced the submission of a regulatory application in the European Union for the investigational once-daily medicine, umeclidinium bromide (UMEC), for patients wi...
GlaxoSmithKline CFO Interviewed on Q1 2013 Financial Results
LONDON, April 24, 2013 /PRNewswire/ -- GlaxoSmithKline reported a 2% decline in Group revenues in line with expectations and a dividend increase of 6% as part of its 2013 Q1 results. The pharmaceutic...
Pharmaceutical giants GlaxoSmithKline (GSK) and Merck are fighting it out in the vaccination market, as countries pick sides in their cervical cancer vaccination programs, states a new report by res...
SAN DIEGO, April 23, 2013 /PRNewswire/ -- Avalon Ventures today announced that it has entered into a collaboration with GlaxoSmithKline (GSK) to fund and launch up to ten early-stage life science...
Events
None
Companies
OncoMed Pharmaceuticals is a clinical-stage company that discovers and develops novel therapeutics targeting cancer stem cells, the cells believed to be capable of driving tumor growth, recurrence and...
One of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and liv...
Seattle Genetics is a clinical-stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and...
MDxHealth is a leading molecular diagnostics company that develops and commercializes oncology-based molecular diagnostic testing for personalized medicine. The companyâs tes...
Bionest Partners Inc. provides strategy consulting services exclusively for the life science industries to help pharmaceutical, biopharmaceutical, diagnostics, biotechnology, and...
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forwardâs products and services have been utilized in o...
Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other s...
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward's products and services have been utilized in over 1...
Regulus Therapeutics is a biopharmaceutical company leading the discovery and development of innovative new medicines based on microRNAs. Regulus is targeting microRNAs as a new c...
Unigene Laboratories, Inc. is a biopharmaceutical company focusing on the oral and nasal delivery of large-market peptide drugs. Due to the size of the worldwide osteoporosis mark...
Clinical Trials
Malaria is an important cause of death and serious illness among Mozambican children. Although the risk of malaria can be reduced by drugs and by impregnated bed nets, it would be helpful...
This study will test the safety and immunogenicity of the gp120/NefTat/AS02A vaccine candidate in individuals with chronic HIV-1 infection successfully treated with HAART. The rationale fo...
A Phase IV Study to Evaluate the Immunogenicity and Safety in UK Laboratory Workers of Menitorix
Menitorix is a combined Hib conjugate and meningococcal C conjugate vaccine made by GlaxoSmithKline. It is currently licensed and recommended as a booster vaccination for UK children in th...
Infection with human papillomavirus (HPV) has been clearly established as the central cause of cervical cancer. The current study is designed to assess the immunogenicity and safety of Gla...
This study aims to evaluate the safety, reactogenicity and immunogenicity of GlaxoSmithKline (GSK) Biologicals´ 10-valent pneumococcal conjugate vaccine when co-administered with diphther...
This study will evaluate safety, reactogenicity and immunogenicity of GSK Biologicals' pneumococcal conjugate vaccine compared to Prevenar™ when co-administered with DTPw-HBV/Hib and OPV...
Human papillomavirus infection has clearly been recognized as the cause of cervical cancer. Indeed, the infection of the cervix by certain oncogenic types of HPV, if not cleared , can lead...
Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women.
The study will be extended for subjects who received all three doses of vaccine in Finland, Denmark and Estonia to determine long-term safety and immunogenicity of the HPV-16/18 vaccine. H...
This protocol posting deals with objectives & outcome measures of the extension phase up to Month 48. The objective of the extension study is to evaluate the long-term immunogenicity of th...
The purpose of this study to look at the antibodies (proteins from the body’s infection fighting system) in the blood of babies delivered by women who are participants in the Herpevac Tr...
PubMed Articles
BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases.
Increasing evidence suggests that synaptic dysfunction is a key pathophysiological hallmark in neurodegenerative disorders, including Alzheimer's disease. Understanding the role of brain-derived neuro...
The Cost and Public Health Burden of Invasive Meningococcal Disease Outbreaks: A Systematic Review.
BACKGROUND: Invasive meningococcal disease (IMD) is a serious disease with a rapid onset, high mortality rate, and risk of long-term complications. Numerous reports in the literature conclude that IMD...
Macrolones are a new class of antimicrobial compounds consisting of a macrolide scaffold linked to a 4-quinolone-3-carboxylic acid moiety via C(4″) position of a macrolide. As macrolides are known t...
INTRODUCTION: Pulmonary arterial hypertension (PAH) is associated with poor prognosis despite significant recent advances in its treatment. An intravenous formulation of epoprostenol sodium containing...
Introduction: Pharmacokinetic drug interactions resulting from the inhibition of drug elimination mechanisms are of concern in drug development due to the clinical risk associated with elevated drug c...
INTRODUCTION: Fluticasone furoate (FF) is a novel inhaled corticosteroid with 24-hour activity. FF is in development as a once-daily treatment for asthma as monotherapy and in combination with vilante...
The potential for development of autoimmune diseases after vaccination with new vaccines containing novel adjuvants is a theoretical concern. Randomised, placebo-controlled trials are the best method...
Promoting remyelination for the treatment of multiple sclerosis: opportunities and challenges.
Multiple sclerosis (MS) is a chronic and devastating autoimmune demyelinating disease of the central nervous system. With the increased understanding of the pathophysiology of this disease in the past...
The primary objective of this investigation was to assess whether the AS04-adjuvanted herpes simplex virus (HSV) glycoprotein D candidate prophylactic vaccine against genital herpes disease increases...
Prevention and control of meningococcal disease.
Meningococcal disease describes the spectrum of infections caused by Neisseria meningiditis, including meningitdis, bacteremia, and bacteremic pneumonia. Two quadrivalent meningococcal polysaccharide-...
Videos
GlaxoSmithKline whistleblower speaks out about bribery of doctors, off-label marketing of drugs
This exclusive interview with former GlaxoSmithKline employee and whistleblower Blair Hamrick reveals insider details of GSK's operations, for which the comp...
